Gyre Therapeutics

Gyre Therapeutics

GYRE· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -41.7% in FY2025

Ping Zhang is the CEO of Gyre Therapeutics and was paid $4.1M in FY2025 (Dec).

Pay$100 in the stock at the end of FY24 → $58
CEO pay is from each Gyre Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Weiguo YeFY2025
  2. 2Ping ZhangFY2025
  3. 3Han Ying, Ph.D.FY2025
  4. 4Ruoyu ChenFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Gyre Therapeutics paid its 4 named executives $9.8M in total in FY2025 (Dec). CEO Ping Zhang was paid $4.1M of that.

Name
Weiguo YeChief Operating OfficerNot disclosed
Ping ZhangInterim Chief Executive OfficerNot disclosedNot disclosed
Han Ying, Ph.D.Senior Vice President, Science and Former Chief Executive OfficerNot disclosed
Ruoyu ChenChief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Gyre Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 27, 2026FY2025
Annual report10-KMar 13, 2026FY2025
Proxy statementDEF 14AApr 21, 2025FY2024
Annual report10-KMar 17, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 27, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data